OVATF (Ovation Science) Days Payable: 0.00 (As of Mar. 2026)


What is Ovation Science Days Payable?

Ovation Science OVATF Days Payable is 0.00 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, Ovation Science ranks better than 98.7% on this metric.

Ovation Science's average Accounts Payable for the three months ended in Mar. 2026 was $0.11 Mil. Ovation Science's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Ovation Science's Days Payable or its related term are showing as below:

OVATF' s Days Payable Range Over the Past 10 Years
Min: 124.68   Med: 941.82   Max: 7650.4
Current: 7650.4

During the past 9 years, Ovation Science's highest Days Payable was 7650.40. The lowest was 124.68. And the median was 941.82.

OVATF's Days Payable is ranked better than
98.7% of 923 companies
in the Drug Manufacturers industry
Industry Median: 90.98 vs OVATF: 7650.40

Ovation Science's Days Payable declined from Mar. 2025 (9,763.75) to Mar. 2026 (0.00). It may suggest that Ovation Science accelerated paying its suppliers.


Ovation Science Days Payable Historical Data

* Premium members only.

The historical data trend for Ovation Science's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ovation Science Days Payable Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only 623.02 2,250.83 1,825.00 1,277.50 5,057.86

Ovation Science Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,763.75 0.00 3,178.54 0.00 0.00

OVATF vs ZTS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Days Payable distribution charts can be found below:

* The bar in red indicates where Ovation Science's Days Payable falls into.



Ovation Science Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ovation Science's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.091 + 0.103) / 2 ) / 0.007*365
=0.097 / 0.007*365
=5,057.86

Ovation Science's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.103 + 0.112) / 2 ) / 0*365 / 4
=0.1075 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Ovation Science (OVATF) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ovation Science and its competitors. Over the past decade, Ovation Science's Days Payable has ranged from 124.68 to 7,650.40. According to the industry distribution chart, Ovation Science ranks #12 out of 923 companies in the Drug Manufacturers industry, placing it in the top 1.3%.
Is Ovation Science's Days Payable too high?
Ovation Science's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 124.68 to a high of 7,650.40. Based on the distribution chart, Ovation Science ranks #12 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Ovation Science's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ovation Science ranks #12 out of 923 companies for Days Payable. This places Ovation Science in the top 1% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.98. Historically, Ovation Science's own Days Payable has ranged from 124.68 to 7,650.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ovation Science and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ovation Science's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ovation Science stock overvalued right now?
Based on GuruFocus' analysis, Ovation Science (OVATF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.04 — trading 16.7% above its estimated fair value. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ovation Science (OVATF), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ovation Science Business Description

Other Exchanges OVAT:Canada
Address 1166 Alberni Street, Suite 1003, Vancouver, BC, CAN, V6E 3Z3
Ovation Science Inc. is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the Ovation brand label, utilizing patented Invisicare delivery technology. The Company operates in one reportable operating segment, the sub-licensing and sales of cannabis products that utilize Invisicare, a patented polymer-based technology for topical and transdermal skin care products.